6-2CSS New Inhaled Corticosteroid/Long-Acting Beta-Agonist (ICS/LABA) Inhalers with 24 Hours Efficacy in Relvar ElliptaTM to Address Patients Needs

Saturday, 17 October 2015: 11:35 - 12:05
Grand Ballroom 102 (Coex Convention Center)

Jo Douglass, MBBS MD , Department of Medicinemedicine, University of Melbourne, Melbourne, Australia

See more of: Asthma: New Insights, New Treatments, New Methodologies
See more of: Company Sponsored Symposia
<< Previous Presentation | Next Presentation